These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18579602)

  • 41. Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies.
    Vigil A; Frias-Staheli N; Carabeo T; Wittekind M
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
    Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
    J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses.
    Di Trani L; Savarino A; Campitelli L; Norelli S; Puzelli S; D'Ostilio D; Vignolo E; Donatelli I; Cassone A
    Virol J; 2007 May; 4():39. PubMed ID: 17477867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low dose oral combination chemoprophylaxis with oseltamivir and amantadine for influenza A virus infections in mice.
    Masihi KN; Schweiger B; Finsterbusch T; Hengel H
    J Chemother; 2007 Jun; 19(3):295-303. PubMed ID: 17594925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stability of different influenza subtypes: How can high hydrostatic pressure be a useful tool for vaccine development?
    Dumard CH; Barroso SPC; Santos ACV; Alves NS; Couceiro JNSS; Gomes AMO; Santos PS; Silva JL; Oliveira AC
    Biophys Chem; 2017 Dec; 231():116-124. PubMed ID: 28410940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes.
    Van Reeth K; Gregory V; Hay A; Pensaert M
    Vaccine; 2003 Mar; 21(13-14):1375-81. PubMed ID: 12615433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)--a new equine influenza virus.
    Webster RG; Thomas TL
    Vaccine; 1993; 11(10):987-93. PubMed ID: 8212831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiviral efficacy against influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model.
    Laure M; Hamza H; Koch-Heier J; Quernheim M; Müller C; Schreiber A; Müller G; Pleschka S; Ludwig S; Planz O
    Antiviral Res; 2020 Jun; 178():104806. PubMed ID: 32304723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus.
    Gautam A; Park BK; Kim TH; Akauliya M; Kim D; Maharjan S; Park J; Kim J; Lee H; Park MS; Lee Y; Kwon HJ
    Front Immunol; 2019; 10():1160. PubMed ID: 31191534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infection of human airway epithelia with H1N1, H2N2, and H3N2 influenza A virus strains.
    Slepushkin VA; Staber PD; Wang G; McCray PB; Davidson BL
    Mol Ther; 2001 Mar; 3(3):395-402. PubMed ID: 11273782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.
    Checkmahomed L; M'hamdi Z; Carbonneau J; Venable MC; Baz M; Abed Y; Boivin G
    J Infect Dis; 2020 Jan; 221(1):63-70. PubMed ID: 31419295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2).
    Tang M; Harp JA; Wesley RD
    Arch Virol; 2002 Nov; 147(11):2125-41. PubMed ID: 12417948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5' sequence: evidence from a plasmid-driven system.
    Duhaut SD; Dimmock NJ
    J Gen Virol; 2002 Feb; 83(Pt 2):403-411. PubMed ID: 11807233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo prophylactic activity of QR-435 against H3N2 influenza virus infection.
    Oxford JS; Lambkin R; Guralnik M; Rosenbloom RA; Petteruti MP; Digian K; LeFante C
    Am J Ther; 2007; 14(5):462-8. PubMed ID: 17890936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biological features of human influenza A(H3N8) viruses in China.
    Zhu W; Chen Q; Xu X; Wei H; Tan M; Yang L; Zou S; Li Z; Lin S; Wang D
    J Med Virol; 2023 Jul; 95(7):e28912. PubMed ID: 37403888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protection against lethal influenza virus challenge by RNA interference in vivo.
    Tompkins SM; Lo CY; Tumpey TM; Epstein SL
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8682-6. PubMed ID: 15173583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A bivalent live-attenuated influenza vaccine for the control and prevention of H3N8 and H3N2 canine influenza viruses.
    Rodriguez L; Nogales A; Murcia PR; Parrish CR; Martínez-Sobrido L
    Vaccine; 2017 Aug; 35(34):4374-4381. PubMed ID: 28709557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of influenza by targeting host receptors using engineered proteins.
    Connaris H; Govorkova EA; Ligertwood Y; Dutia BM; Yang L; Tauber S; Taylor MA; Alias N; Hagan R; Nash AA; Webster RG; Taylor GL
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6401-6. PubMed ID: 24733924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-influenza virus activity of tricin, 4',5,7-trihydroxy-3',5'-dimethoxyflavone.
    Yazawa K; Kurokawa M; Obuchi M; Li Y; Yamada R; Sadanari H; Matsubara K; Watanabe K; Koketsu M; Tuchida Y; Murayama T
    Antivir Chem Chemother; 2011 Aug; 22(1):1-11. PubMed ID: 21860068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.